Concepedia

Josh D. Silvertown

JD

Statistics

Publications

16

Citations

721

H-Index

13

Active since

2003

Affiliations

University Health Network(Current)

University of Toronto

University of Guelph

Ontario Institute for Cancer Research

The University of Texas at San Antonio Health Science Center

Josh D. Silvertown is an author at University Health Network specializing in medicine, oncology, and molecular oncology.

Publications per year

2003–2022

16

Publications

16

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma

Steven G. Waguespack, Alexander Drilon, Marcia S. Brose et al. · The Medicine Forum · 2022 · 125 citations · Full text

, , +15

Paracrine effects of transplanted myoblasts and relaxin on post‐infarction heart remodelling

Lucia Formigli, Avio‐Maria Perna, Elisabetta Meacci et al. · Journal of Cellular and Molecular Medicine · 2007 · 89 citations · Full text

, , +17

H2 relaxin overexpression increases <i>in vivo</i> prostate xenograft tumor growth and angiogenesis

Josh D. Silvertown, Jonathan Ng, Takeya Sato et al. · International Journal of Cancer · 2005 · 87 citations · Full text

, , +15

Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells

Sabine Hombach‐Klonisch, Joanna Białek, Bogusz Trojanowicz et al. · American Journal Of Pathology · 2006 · 75 citations · Full text

, , +9

Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth

Josh D. Silvertown, Juliane C. Symes, Anton Neschadim et al. · The FASEB Journal · 2006 · 60 citations

, , +17

1–5 of 16